The patient underwent aortic valve replacement, mitral valve replacement and coronary artery bypass grafting (cabg) on (b)(6) 2012.An edwards magna ease (size unknown) was implanted in the aortic position and a 25mm sjm epic valve was implanted in the mitral position.No anomalies or issues were reported during the surgical procedure and perioperative period.Post discharge, the patient was followed-up at another facility where on (b)(6) 2013, mitral regurgitation grade 1 was noted.In (b)(6) 2014, at follow-up, mitral regurgitation grade 3 was noted.On (b)(6) 2014, mitral regurgitation grade 4 was noted and the patient had a cardiac arrest.On (b)(6) 2014, when the patient was in stable condition, a redo mitral valve replacement was performed.The 25mm sjm epic valve was explanted and a 27mm sjm epic valve was implanted.Upon explant, one cusp was noted to be horizontally torn from the anterior leaflet (a2) to the commissure position facing the aortic valve.The patient is recovering per report.
|
(b)(4).The results of this investigation concluded there was focal fibrous thickening of cusp 1 with incomplete coaptation, and a tear in cusp 3.Special stains revealed mixed gram positive rods and cocci.The clusters of mixed gram positive bacteria were seen predominantly on the surfaces of the cusps and without an inflammatory response.This likely represented a contaminant.No acute inflammation or significant calcifications were observed.There was no evidence found to suggest the cause of the fibrin, cuspal tear, and gram positive bacteria were due to an intrinsic defect in the valve, as supported by review of the valve's device history record and the analysis performed.The cause of the fibrin, cuspal tear, and gram positive bacteria remains unknown.
|